<?xml version="1.0" encoding="UTF-8"?>
<p id="p0165">Isolation is the main stay of prevention. Vaccine for COVID-19 is currently under phase 1 trial. Recently a mRNA-1273 vaccine that targets the Spike (S) protein of the coronavirus has been manufactured by Vaccine Research Center, Moderna (a unit of the National Institute of Allergy and Infectious Diseases) in USA. The trial began on 16 March at the Kaiser Permanente Washington Health Research Institute in Seattle, Washington in total of 45 males and females aged between 18 and 45 where the participants will be divided into three cohorts and will be administered 25 μg (mcg), 100mcg or 250mcg dose 28 days apart.</p>
